Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Neoplastic Processes
>>
Novartis
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Tafinlar
(dabrafenib) / Novartis, BeiGene
patupilone
(EPO 906) / Novartis
vatalanib
(PTK787) / Novartis, Bayer
Jakafi
(ruxolitinib) / Incyte
buparlisib
(AN2025) / Novartis, Adlai Nortye, Nippon Kayaku